Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1

Season 6, Episode 28,  Feb 17, 2022, 07:55 PM

Dr Milhem discusses the unique mechanism of action and delivery method of RP1, which is being evaluated in the IGNYTE trial for patients with solid tumors, as well as the parallel studies ARTACUS and CERPASS, which are further exploring the agent.